Hangzhou Alltest Biotech Co., Ltd.
public_traded
Hangzhou Alltest Biotech Co., Ltd. is publicly traded on SHH under ticker 688606.SS.
Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and market of in vitro diagnostic reagents worldwide. It offers rapid diagnostic products, including women's health, infectious diseases, drugs, cancer, cardiovascular, and other five series of products. The company is based in Hangzhou, China.